Studies in urinary system cancer have shown that renal cancer patients with low expression of ANXA1 have a better prognosis, and Yu’s study showed that high expression of ANXA1 was associated with recurrence of bladder cancer (Yu et al., 2014; Yamanoi et al., 2019). The gene discussed is ANXA1; the disease is renal carcinoma.